Cargando…

Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy

INTRODUCTION: Pheochromocytoma is a catecholamine-producing tumor in the adrenal medulla and is often accompanied by hypertension, hyperglycemia, hypermetabolism, headache, and hyperhidrosis, and it is classified as benign and malignant pheochromocytoma. In addition, persistent hypertension is often...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneto, Hideaki, Kamei, Shinji, Tatsumi, Fuminori, Shimoda, Masashi, Kimura, Tomohiko, Nakanishi, Shuhei, Miyaji, Yoshiyuki, Nagai, Atsushi, Kaku, Kohei, Mune, Tomoatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267922/
https://www.ncbi.nlm.nih.gov/pubmed/34248848
http://dx.doi.org/10.3389/fendo.2021.688536
_version_ 1783720250471088128
author Kaneto, Hideaki
Kamei, Shinji
Tatsumi, Fuminori
Shimoda, Masashi
Kimura, Tomohiko
Nakanishi, Shuhei
Miyaji, Yoshiyuki
Nagai, Atsushi
Kaku, Kohei
Mune, Tomoatsu
author_facet Kaneto, Hideaki
Kamei, Shinji
Tatsumi, Fuminori
Shimoda, Masashi
Kimura, Tomohiko
Nakanishi, Shuhei
Miyaji, Yoshiyuki
Nagai, Atsushi
Kaku, Kohei
Mune, Tomoatsu
author_sort Kaneto, Hideaki
collection PubMed
description INTRODUCTION: Pheochromocytoma is a catecholamine-producing tumor in the adrenal medulla and is often accompanied by hypertension, hyperglycemia, hypermetabolism, headache, and hyperhidrosis, and it is classified as benign and malignant pheochromocytoma. In addition, persistent hypertension is often observed in subjects with malignant pheochromocytoma. CASE PRESENTATION: A 52-year-old Japanese male was referred and hospitalized in our institution. He had a health check every year and no abnormalities had been pointed out. In addition, he had no past history of hypertension. In endocrinology markers, noradrenaline level was as high as 7,693 pg/ml, whereas adrenaline level was within normal range. Abdominal contrast-enhanced computed tomography revealed a 50-mm hyper-vascularized tumor with calcification in the right adrenal gland and multiple hyper-vascularized tumors in the liver. In (131)I MIBG scintigraphy, there was high accumulation in the right adrenal gland and multiple accumulation in the liver and bone. In echocardiography, left ventricular ejection fraction was as low as 14.3%. In coronary angiography, however, there was no significant stenosis in the coronary arteries. Based on these findings, we finally diagnosed him as malignant pheochromocytoma accompanied by multiple liver and bone metastases and catecholamine cardiomyopathy. However, blood pressure was continuously within normal range without any anti-hypertensive drugs. Right adrenal tumor resection was performed together with left hepatic lobectomy and cholecystectomy. Furthermore, serum levels of vascular endothelial growth factor (VEGF) and parathyroid (PTH)-related protein were very high before the operation but they were markedly reduced after the operation. CONCLUSIONS: This is the first report showing the time course of serum VEGF level in a subject with malignant pheochromocytoma, clearly showing that malignant pheochromocytoma actually secreted VEGF. In addition, this case report clearly shows that we should bear in mind once again that malignant pheochromocytoma is not necessarily accompanied by hypertension.
format Online
Article
Text
id pubmed-8267922
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82679222021-07-10 Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy Kaneto, Hideaki Kamei, Shinji Tatsumi, Fuminori Shimoda, Masashi Kimura, Tomohiko Nakanishi, Shuhei Miyaji, Yoshiyuki Nagai, Atsushi Kaku, Kohei Mune, Tomoatsu Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Pheochromocytoma is a catecholamine-producing tumor in the adrenal medulla and is often accompanied by hypertension, hyperglycemia, hypermetabolism, headache, and hyperhidrosis, and it is classified as benign and malignant pheochromocytoma. In addition, persistent hypertension is often observed in subjects with malignant pheochromocytoma. CASE PRESENTATION: A 52-year-old Japanese male was referred and hospitalized in our institution. He had a health check every year and no abnormalities had been pointed out. In addition, he had no past history of hypertension. In endocrinology markers, noradrenaline level was as high as 7,693 pg/ml, whereas adrenaline level was within normal range. Abdominal contrast-enhanced computed tomography revealed a 50-mm hyper-vascularized tumor with calcification in the right adrenal gland and multiple hyper-vascularized tumors in the liver. In (131)I MIBG scintigraphy, there was high accumulation in the right adrenal gland and multiple accumulation in the liver and bone. In echocardiography, left ventricular ejection fraction was as low as 14.3%. In coronary angiography, however, there was no significant stenosis in the coronary arteries. Based on these findings, we finally diagnosed him as malignant pheochromocytoma accompanied by multiple liver and bone metastases and catecholamine cardiomyopathy. However, blood pressure was continuously within normal range without any anti-hypertensive drugs. Right adrenal tumor resection was performed together with left hepatic lobectomy and cholecystectomy. Furthermore, serum levels of vascular endothelial growth factor (VEGF) and parathyroid (PTH)-related protein were very high before the operation but they were markedly reduced after the operation. CONCLUSIONS: This is the first report showing the time course of serum VEGF level in a subject with malignant pheochromocytoma, clearly showing that malignant pheochromocytoma actually secreted VEGF. In addition, this case report clearly shows that we should bear in mind once again that malignant pheochromocytoma is not necessarily accompanied by hypertension. Frontiers Media S.A. 2021-06-25 /pmc/articles/PMC8267922/ /pubmed/34248848 http://dx.doi.org/10.3389/fendo.2021.688536 Text en Copyright © 2021 Kaneto, Kamei, Tatsumi, Shimoda, Kimura, Nakanishi, Miyaji, Nagai, Kaku and Mune https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Kaneto, Hideaki
Kamei, Shinji
Tatsumi, Fuminori
Shimoda, Masashi
Kimura, Tomohiko
Nakanishi, Shuhei
Miyaji, Yoshiyuki
Nagai, Atsushi
Kaku, Kohei
Mune, Tomoatsu
Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title_full Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title_fullStr Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title_full_unstemmed Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title_short Case Report: Malignant Pheochromocytoma Without Hypertension Accompanied by Increment of Serum VEGF Level and Catecholamine Cardiomyopathy
title_sort case report: malignant pheochromocytoma without hypertension accompanied by increment of serum vegf level and catecholamine cardiomyopathy
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267922/
https://www.ncbi.nlm.nih.gov/pubmed/34248848
http://dx.doi.org/10.3389/fendo.2021.688536
work_keys_str_mv AT kanetohideaki casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT kameishinji casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT tatsumifuminori casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT shimodamasashi casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT kimuratomohiko casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT nakanishishuhei casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT miyajiyoshiyuki casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT nagaiatsushi casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT kakukohei casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy
AT munetomoatsu casereportmalignantpheochromocytomawithouthypertensionaccompaniedbyincrementofserumvegflevelandcatecholaminecardiomyopathy